Open tender · Taiwan · Public tender
脊髓性肌肉萎縮症(SMA)、X染色體脆折症(Fragile X)基因檢驗、Y染色體片段缺失突變檢測及海洋性貧血基因篩檢(血液、羊水、流產物)
In EnglishSpinal Muscular Atrophy (SMA), Fragile X Syndrome, Y Chromosome Deletion Mutation Detection, and Thalassemia Gene Screening (Blood, Amniotic Fluid, Abortion Products)
國立成功大學醫學院附設醫院 in Taiwan is inviting bids for “Spinal Muscular Atrophy (SMA), Fragile X Syndrome, Y Chromosome Deletion Mutation Detection, and Thalassemia Gene Screening (Blood, Amniotic Fluid…”. Bids close on 12 October 2026, 17:00 GMT+8; the estimated value is TWD 4.84 million. askTender lists every requirement to qualify and checks whether your company meets them.
Key facts
- Estimated value
- TWD 4.84 million
- Procedure
- 公開招標公告
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: 行政院公共工程委員會 政府電子採購網; retrieved via g0v pcc-api.openfun.app. · Sources & licences